National Security Controls and the Life Sciences Sector: BIOSECURE Act, Section 1260H, and COINS Act Developments
Following the U.S. Department of Defense’s addition of WuXi AppTec and other biotech companies to its list of Chinese military companies, these entities may soon face restrictions under the BIOSECURE…
Read the full articleYou might also wanna read
U.S. restrictions on Chinese biotech could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
econ.st·20d ago
U.S. restrictions on Chinese biotech could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
economist.com·20d agoU.S. restrictions on Chinese biotech could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
The Economist·20d agoWhat the Updated 1260H List Means for Biotechnology Procurement
On June 8, 2026, the Department of War (“DoW”) published its updated list of “Chinese military companies” operating in the United States (“1
U.S. restrictions on Chinese biotechnology could harm patients, argues editorial
Patients benefit from faster, cheaper treatments, wherever they are invented
econ.st·21d ago
US Department of Defense Adds Novogene, WuXi AppTech, Complete Genomics to Watchlist
An update to the so-called “1260H” list alleges that these companies are indirectly owned by or affiliated with the Chinese military and nat
The case for bioliteracy: Exploring biotech’s role in national security
The continued faceoff between WuXi AppTec and the US government highlights the need for a biotech-savvy citizenry.
Comments
Sign in to join the conversation.
No comments yet. Be the first.